RHÖN-KLINIKUM Aktiengesellschaft (RKAGY) Stock Price, News & Analysis

Company Overview

RHÖN-KLINIKUM Aktiengesellschaft is a Germany-based hospital group specializing in acute care and rehabilitation services. Headquartered in Bad Neustadt an der Saale, the company operates a network of acute-care hospitals, rehabilitation clinics and outpatient medical service centers. Through its subsidiaries, RHÖN-KLINIKUM provides surgical, diagnostic and therapeutic treatments across a range of medical disciplines, including cardiology, oncology, orthopedics and neurology.

The group’s core business activities encompass inpatient acute care, surgical interventions and multi-specialty rehabilitation programs aimed at restoring patient mobility and function. In addition to clinical services, the company offers diagnostic imaging, laboratory testing and outpatient follow-up care. RHÖN-KLINIKUM has invested in modern hospital infrastructure and digital health solutions to support seamless patient management and improve clinical outcomes.

RHÖN-KLINIKUM primarily serves regional markets in Germany, with facilities distributed across several federal states. Its hospitals and rehabilitation centers cater to both urban and rural communities, strengthening access to specialized health care in underserved areas. The company collaborates with local physicians, insurers and academic partners to facilitate clinical research and expand its continuum of care.

Founded in the mid-1970s, RHÖN-KLINIKUM has grown from a single hospital operation into one of Germany’s largest private hospital operators. In 2013, Fresenius SE & Co. KGaA acquired a controlling interest, positioning RHÖN-KLINIKUM within a global health care group. Under its current organizational structure, RHÖN-KLINIKUM continues to focus on delivering high-quality patient care, expanding its service portfolio and optimizing operational efficiency.

Key Stats

• Today's Range: $7.37 to $7.37
• 50-Day Range: $7.37 to $7.37
• 52-Week Range: $7.31 to $9.07
• Volume: N/A
• Average Volume: 229 shs
• Market Capitalization: N/A
• P/E Ratio: 1.64
• Dividend Yield: 1.12%
• Price Target: N/A
• Consensus Rating: N/A

RHÖN-KLINIKUM Aktiengesellschaft Stock Analysis - MarketRank™

RHÖN-KLINIKUM Aktiengesellschaft scored higher than 36% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for RHÖN-KLINIKUM Aktiengesellschaft.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of RHÖN-KLINIKUM Aktiengesellschaft is 1.64, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 82.65.

Price to Earnings Ratio vs. Sector

The P/E ratio of RHÖN-KLINIKUM Aktiengesellschaft is 1.64, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.66.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

RHÖN-KLINIKUM Aktiengesellschaft has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in RHÖN-KLINIKUM Aktiengesellschaft has recently decreased by 33.33%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

RHÖN-KLINIKUM Aktiengesellschaft is a leading dividend payer. It pays a dividend yield of 5.34%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

RHÖN-KLINIKUM Aktiengesellschaft does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of RHÖN-KLINIKUM Aktiengesellschaft is 1.83%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

RHÖN-KLINIKUM Aktiengesellschaft has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in RHÖN-KLINIKUM Aktiengesellschaft has recently decreased by 33.33%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: N/A

News Sentiment

RHÖN-KLINIKUM Aktiengesellschaft has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, RHÖN-KLINIKUM Aktiengesellschaft insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.17% of the stock of RHÖN-KLINIKUM Aktiengesellschaft is held by institutions.

RKAGY Stock Analysis - Frequently Asked Questions

How have RKAGY shares performed this year?

RHÖN-KLINIKUM Aktiengesellschaft's stock was trading at $6.05 on January 1st, 2025. Since then, RKAGY stock has increased by 21.8% and is now trading at $7.37.

How do I buy shares of RHÖN-KLINIKUM Aktiengesellschaft?

Shares of RKAGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 10/23/2025
• Next Earnings (Estimated): 11/06/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:RKAGY
• CIK: N/A
• Web: www.rhoen-klinikum-ag.com
• Phone: 499771650
• Fax: N/A
• Employees: 18,282
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 1.64
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A